The Prevalence of Autoimmune Antibodies in Patients with Type 2 Diabetes Managed by Endocrinology Vs. Primary Care
NCT05553145 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 200
Last updated 2025-01-10
Summary
The purpose of this study is to assess the levels of autoimmune markers of diabetes in those with a type 2 diabetes diagnosis.
Conditions
Interventions
- DIAGNOSTIC_TEST
-
Autoimmune Antibody Assays
GAD-65, Islet cell-Ab, IA-2 Ab, anti-insulin Ab, and ZnTn8 Ab
Sponsors & Collaborators
-
The Cleveland Clinic
lead OTHER
Principal Investigators
-
Kevin Pantalone, DO · The Cleveland Clinic
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2022-09-01
- Primary Completion
- 2023-05-31
- Completion
- 2024-08-29
Countries
- United States
Study Locations
More Related Trials
-
Evaluation of Biomarker Expression in Diabetic and Healthy Subjects Over a One Year Period
NCT01900834 ·Status: COMPLETED
-
Gender Differences in Prevalence of Undiagnosed Diabetes in ACS
NCT00589459 ·Status: COMPLETED
-
Cardiac CT's Role in Asymptomatic Patients With Diabetes and Metabolic Syndrome
NCT01564485 ·Status: COMPLETED ·Phase: NA
-
Validation of the Diabetes Deep Neural Network Score for Diabetes Mellitus Screening
NCT05303051 ·Status: WITHDRAWN ·Phase: NA
-
C-reactive Protein and Endothelial Dysfunction in Women With Glucose Intolerance
NCT00589355 ·Status: COMPLETED
-
Metabolic Phenotypes and Heterogeneity in Disease Burden Risk in Type 1 Diabetes
NCT05609279 ·Status: COMPLETED
-
Comparison of Th1 Cytokine Levels Between Type 1 and Type 2 Diabetes
NCT02860611 ·Status: COMPLETED
-
Developement of Questionnaire to Evaluate a Regularity of Lifestyle in Type 2 Diabetic Patients
NCT00455988 ·Status: UNKNOWN
-
The Effects of add-on Anti-diabetic Drugs in Type 2 Diabetic Patients
NCT02885922 ·Status: UNKNOWN
-
Korea National Diabetes Program
NCT01212198 ·Status: UNKNOWN
-
Evaluation of the Targeted Screening of Type 2 Diabetes by Capillary Blood Glucose
NCT02440555 ·Status: COMPLETED
-
Clinical Characteristics of People With Long-term Type 1 Diabetes
NCT05359796 ·Status: RECRUITING
-
Immune Profile and Complication Risk in Type 2 Diabetes
NCT00674271 ·Status: UNKNOWN
-
Heterogeneity of Diabetes: Integrated Muli-Omics to Identify Physiologic Subphenotypes and Evaluate Targeted Prevention
NCT06682351 ·Status: NOT_YET_RECRUITING ·Phase: PHASE4
-
Changes in Arterial Stiffness and Endothelial Glycocalyx in Patients With Poorly Controlled Diabetes Mellitus Type 1 or Type 2 After Optimization of Antidiabetic Medication.
NCT03010956 ·Status: COMPLETED
-
A Study of Blood Metabolic Markers in Patients With Type 2 Diabetes Mellitus of Different Stages
NCT06155539 ·Status: NOT_YET_RECRUITING
-
Relation of White Blood Cell Function to Diabetes
NCT00570154 ·Status: COMPLETED
-
Progression of Coronary Atherosclerosis in Asymptomatic Diabetic Subjects
NCT02109835 ·Status: UNKNOWN
-
Description of an Immune Activation Profile Linked to Insulin Resistance in Subjects Aged 55-69
NCT03309761 ·Status: COMPLETED
-
Changes in Skin Innervation of Neurologically Asymptomatic Type 2 Diabetic Patients: the Correlation With the Diabetic Parameters and Neurotrophins.
NCT00155142 ·Status: UNKNOWN
-
Egg Intake and Risk of Type 2 Diabetes
NCT03406910 ·Status: COMPLETED
-
Characterization of Type 2 Diabetes Subgroups at Diagnosis: a Necessary Step Towards Precision Medicine in Diabetes.
NCT05333718 ·Status: RECRUITING
-
Therapeutic Innovation in Type 2 DIABetes (IT-DIAB)
NCT01218061 ·Status: UNKNOWN ·Phase: NA
-
Salivary Transcriptome Biomarkers for Early Diabetes Detection
NCT02673762 ·Status: UNKNOWN
-
Type 2 Diabetes and Acute Myocardial Infarction
NCT00926133 ·Status: UNKNOWN